AI-generated summary
In a hamster model of chemically induced oral cancer, the authors compared low-intensity laser at 660 nm, topical imiquimod, and their combination against controls. The authors report that imiquimod alone was associated with absence of malignant tumors in 60 percent of animals and more S-100 positive dendritic cells, while the combination group had 40 percent with squamous cell carcinoma.
- Participants
- 25
- Who or what was studied
- Hamsters with chemically induced squamous cell carcinoma of the buccal pouch mucosa
- Wavelengths
- 660 nm
- Limits stated in the abstract
- The study is an animal experiment with small groups and the abstract suggests the imiquimod and laser combination needs further investigation.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on link.springer.com.
Record from PubMed, a service of the National Library of Medicine.
Light parameters mentioned
Found in the title and abstract by pattern. They may be incomplete, so check the paper before comparing studies.
- Wavelength
- 660 nm
- Power
- 50 mW
- Total energy
- 6.65 J
How to read a single study: what to check before relying on this kind of research.
Terms in this paper: Laser, Low-level laser therapy. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.